Milestones
Scroll to explore
2011-12 - Inception and Strong Foundation
The company was incorporated in FY 2011–12 and achieved an impressive turnover of around ₹10 Crores in its very first year of operations. Despite limited resources and infrastructure, Sorich successfully catered to the food packaging industry, laying a strong foundation for future growth. This early success reflected the company’s commitment to quality, customer satisfaction, and operational efficiency. The year marked the beginning of Sorich’s journey as an emerging player in the packaging sector, driven by innovation, determination, and a clear vision for sustainable growth.
2011-12 - Inception and Strong Foundation
The company was incorporated in FY 2011–12 and achieved an impressive turnover of around ₹10 Crores in its very first year of operations. Despite limited resources and infrastructure, Sorich successfully catered to the food packaging industry, laying a strong foundation for future growth. This early success reflected the company’s commitment to quality, customer satisfaction, and operational efficiency. The year marked the beginning of Sorich’s journey as an emerging player in the packaging sector, driven by innovation, determination, and a clear vision for sustainable growth.
2013-14 - Entry into Pharma Packaging Segment
In FY 2013–14, the company diversified its product portfolio by venturing into the pharmaceutical packaging segment, marking a major step in its growth journey. During this period, Sorich secured substantial orders from leading pharmaceutical companies such as Ajanta Pharma Limited and Zydus Pharmaceutical Limited, establishing its credibility as a reliable and quality-driven supplier. With a turnover of ₹22.83 Crores, the year reflected significant progress and growing trust among reputed industry players. This strategic expansion not only strengthened the company’s market presence but also reinforced its commitment to delivering innovative, safe, and high-performance packaging solutions tailored to the stringent requirements of the pharma industry.
2014-15 - Innovation and Global Market Expansion
FY 2014–15 marked one of the most significant milestones in Sorich’s journey with the development of Child-Resistant (CR) Foil, a breakthrough innovation in the field of pharmaceutical packaging. The product received prestigious certification from IVM, Germany, opening new avenues for the company in the highly regulated European pharma market.
2017-18 - Introduction of Sustainable Products
Launched a new line of sustainable and eco-friendly products, offering 100% biodegradable alternatives to single-use plastics under the brand name ECORICH. This initiative marked a significant step towards environmental responsibility and innovation in packaging solutions. The ECORICH range is designed to decompose naturally without harming the ecosystem, addressing one of the most pressing global challenges — plastic pollution. By introducing these products, the company reinforced its commitment to sustainability, circular economy principles, and green manufacturing practices. This milestone reflects Sorich’s vision to blend technological advancement with environmental consciousness, paving the way for a future where performance, quality, and sustainability go hand in han
2024-25 - Global Expansion and Excellence
Recorded an impressive turnover of ₹45 Crores, reflecting consistent growth and strong business fundamentals. The year marked a significant milestone in Sorich’s journey towards global recognition, with exports expanding to regions such as Oman, Egypt, South America, North America, and Bangladesh, accounting for nearly 40% of the total turnover. This achievement underscores Sorich’s rising global footprint, robust operational capabilities, and unwavering focus on quality and innovation. Strengthened by long-term relationships with international clients and partners, the company continues to deliver world-class solutions while maintaining sustainability and excellence at its core. The company also proudly holds two registered patents, highlighting its commitment to technological advancement and product innovation”.